FluoGuide A/S (STO:FLUO)
Sweden · Delayed Price · Currency is SEK 40.60
+1.80 (4.64%)
Jul 3, 2026, 3:33 PM CET
FluoGuide Market Cap
FluoGuide has a market cap or net worth of 663.78 million as of July 2, 2026. Its market cap has increased by 25.93% in one year.
Market Cap
663.78M
Enterprise Value
611.94M
Revenue
349.42K
Ranking
n/a
PE Ratio
n/a
Stock Price
40.60
Market Cap Chart
Since May 13, 2019, FluoGuide's market cap has increased from 40.02M to 663.78M, an increase of 1,558.52%. That is a compound annual growth rate of 48.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 663.78M | 18.37% |
| Dec 30, 2025 | 560.78M | 5.17% |
| Dec 30, 2024 | 533.23M | -28.57% |
| Dec 29, 2023 | 746.52M | 68.50% |
| Dec 30, 2022 | 443.04M | -54.38% |
| Dec 30, 2021 | 971.21M | 4.81% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| May 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medivir AB | 1.07B |
| SynAct Pharma AB | 1.05B |
| Infant Bacterial Therapeutics AB | 941.65M |
| Xspray Pharma AB | 723.58M |
| AlzeCure Pharma AB | 712.47M |
| Oncopeptides AB | 649.85M |
| Cantargia AB | 523.08M |
| Corline Biomedical AB | 482.16M |